These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

434 related items for PubMed ID: 2045467

  • 1. 3 alpha-androstanediol glucuronide in virilizing congenital adrenal hyperplasia: a useful serum metabolic marker of integrated adrenal androgen secretion.
    Pang S, MacGillivray M, Wang M, Jeffries S, Clark A, Rosenthal I, Wiegensberg M, Riddick L.
    J Clin Endocrinol Metab; 1991 Jul; 73(1):166-74. PubMed ID: 2045467
    [Abstract] [Full Text] [Related]

  • 2. Normal and elevated 3 alpha-androstanediol glucuronide concentrations in women with various causes of hirsutism and its correlation with degree of hirsutism and androgen levels.
    Pang S, Wang M, Jeffries S, Riddick L, Clark A, Estrada E.
    J Clin Endocrinol Metab; 1992 Jul; 75(1):243-8. PubMed ID: 1535633
    [Abstract] [Full Text] [Related]

  • 3. Serum 3 alpha-androstanediol glucuronide measurements in children with congenital adrenal hyperplasia.
    Hatun S, Yordam N, Calikoğlu AS.
    Eur J Endocrinol; 1994 Nov; 131(5):504-8. PubMed ID: 7952161
    [Abstract] [Full Text] [Related]

  • 4. 3 alpha-Androstanediol glucuronide in premature and normal pubarche.
    Riddick LM, Garibaldi LR, Wang ME, Senne AR, Klimah PE, Clark AT, Levine LS, Oberfield SE, Pang SY.
    J Clin Endocrinol Metab; 1991 Jan; 72(1):46-50. PubMed ID: 1846006
    [Abstract] [Full Text] [Related]

  • 5. Serum 3 alpha-androstanediol glucuronide measurements in sexually mature women with congenital adrenal hyperplasia during therapy.
    Reiner BJ, Donohoue PA, Migeon CJ, Berkovitz GD.
    J Clin Endocrinol Metab; 1989 Jul; 69(1):105-9. PubMed ID: 2732292
    [Abstract] [Full Text] [Related]

  • 6. Serum 21-Deoxycortisol, 17-Hydroxyprogesterone, and 11-deoxycortisol in classic congenital adrenal hyperplasia: clinical and hormonal correlations and identification of patients with 11beta-hydroxylase deficiency among a large group with alleged 21-hydroxylase deficiency.
    Tonetto-Fernandes V, Lemos-Marini SH, Kuperman H, Ribeiro-Neto LM, Verreschi IT, Kater CE.
    J Clin Endocrinol Metab; 2006 Jun; 91(6):2179-84. PubMed ID: 16551734
    [Abstract] [Full Text] [Related]

  • 7. Serum levels of 5-androstene-3 beta,17 beta-diol sulphate, 5 alpha-androstane-3 alpha, 17beta-diol sulphate and glucuronide, in late onset 21-hydroxylase deficiency.
    Montalto J, Funder JW, Yong AB, Whorwood CB, Connelly JF.
    J Steroid Biochem Mol Biol; 1990 Nov 30; 37(4):593-8. PubMed ID: 2177625
    [Abstract] [Full Text] [Related]

  • 8. Plasma progesterone, 17-hydroxyprogesterone, androstenedione and testosterone in prepubertal, pubertal and adult subjects with congenital virilizing adrenal hyperplasia as indicators of adrenal suppression.
    Lee PA, Urban MD, Gutai JP, Migeon CJ.
    Horm Res; 1980 Nov 30; 13(6):347-57. PubMed ID: 7196877
    [Abstract] [Full Text] [Related]

  • 9. Acute adrenocorticotropin-(1-24) (ACTH) adrenal stimulation in eumenorrheic women: reproducibility and effect of ACTH dose, subject weight, and sampling time.
    Azziz R, Bradley E, Huth J, Boots LR, Parker CR, Zacur HA.
    J Clin Endocrinol Metab; 1990 May 30; 70(5):1273-9. PubMed ID: 2139878
    [Abstract] [Full Text] [Related]

  • 10. Profiles of 21-Carbon Steroids in 21-hydroxylase Deficiency.
    Turcu AF, Rege J, Chomic R, Liu J, Nishimoto HK, Else T, Moraitis AG, Palapattu GS, Rainey WE, Auchus RJ.
    J Clin Endocrinol Metab; 2015 Jun 30; 100(6):2283-90. PubMed ID: 25850025
    [Abstract] [Full Text] [Related]

  • 11. Plasma 3 alpha-androstanediol glucuronide in normal children and in congenital adrenal hyperplasia due to 21-hydroxylase deficiency.
    Lopes LA, Catzeflis C, Cicotti I, Rey C, Sizonenko PC.
    Horm Res; 1997 Jun 30; 48(1):35-40. PubMed ID: 9195208
    [Abstract] [Full Text] [Related]

  • 12. The hypothalamic-pituitary-adrenal axis in partial (late-onset) 21-hydroxylase deficiency.
    Feuillan P, Pang S, Schürmeyer T, Avgerinos PC, Chrousos GP.
    J Clin Endocrinol Metab; 1988 Jul 30; 67(1):154-60. PubMed ID: 2837498
    [Abstract] [Full Text] [Related]

  • 13. Dexamethasone suppressibility and adrenal and ovarian venous effluents of 5α-reduced C19 conjugates in hyperandrogenic women.
    Stanczyk FZ, Saxena T, Lobo RA.
    J Steroid Biochem Mol Biol; 2014 Jan 30; 139():73-7. PubMed ID: 24121067
    [Abstract] [Full Text] [Related]

  • 14. Alternate day prednisone therapy in congenital adrenal hyperplasia: adrenal androgen suppression and normal growth.
    Linder B, Feuillan P, Chrousos GP.
    J Clin Endocrinol Metab; 1989 Jul 30; 69(1):191-5. PubMed ID: 2543690
    [Abstract] [Full Text] [Related]

  • 15. Molecular characterization of a Leydig cell tumor presenting as congenital adrenal hyperplasia.
    Solish SB, Goldsmith MA, Voutilainen R, Miller WL.
    J Clin Endocrinol Metab; 1989 Dec 30; 69(6):1148-52. PubMed ID: 2555382
    [Abstract] [Full Text] [Related]

  • 16. Isolated precocious pubarche: an approach.
    Balducci R, Boscherini B, Mangiantini A, Morellini M, Toscano V.
    J Clin Endocrinol Metab; 1994 Aug 30; 79(2):582-9. PubMed ID: 8045980
    [Abstract] [Full Text] [Related]

  • 17. Androsterone sulfate: physiology and clinical significance in hirsute women.
    Zwicker H, Rittmaster RS.
    J Clin Endocrinol Metab; 1993 Jan 30; 76(1):112-6. PubMed ID: 8380602
    [Abstract] [Full Text] [Related]

  • 18. Prenatal dexamethasone treatment in pregnancies at risk for congenital adrenal hyperplasia due to 21-hydroxylase deficiency: effect on midgestational amniotic fluid steroid levels.
    Dörr HG, Sippell WG.
    J Clin Endocrinol Metab; 1993 Jan 30; 76(1):117-20. PubMed ID: 8421074
    [Abstract] [Full Text] [Related]

  • 19. Adrenal function in hirsutism I. Diurnal change and response of plasma androstenedione, testosterone, 17-hydroxyprogesterone, cortisol, LH and FSH to dexamethasone and 1/2 unit of ACTH.
    Givens JR, Andersen RN, Ragland JB, Wiser WL, Umstot ES.
    J Clin Endocrinol Metab; 1975 Jun 30; 40(6):988-1000. PubMed ID: 166091
    [Abstract] [Full Text] [Related]

  • 20. Crinecerfont Lowers Elevated Hormone Markers in Adults With 21-Hydroxylase Deficiency Congenital Adrenal Hyperplasia.
    Auchus RJ, Sarafoglou K, Fechner PY, Vogiatzi MG, Imel EA, Davis SM, Giri N, Sturgeon J, Roberts E, Chan JL, Farber RH.
    J Clin Endocrinol Metab; 2022 Feb 17; 107(3):801-812. PubMed ID: 34653252
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 22.